AGTC

13 Biotechnology Stocks to Sell Now

By Portfolio Grader
This week, the ratings of 13 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

8 Biotechnology Stocks to Buy Now

By Portfolio Grader
This week, eight biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

5 Gene Therapy Stocks to Consider

By James Brumley, InvestorPlace Feature Writer
Gene therapy is back, and this time looks like it's worth the effort. Five names stand out among the whole lot.
Load More